Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · IEX Real-Time Price · USD
7.53
+0.09 (1.21%)
At close: Mar 28, 2024, 4:00 PM
7.39
-0.14 (-1.86%)
After-hours: Mar 28, 2024, 7:21 PM EDT
Health Catalyst Market Cap
Health Catalyst has a market cap or net worth of $440.98 million as of March 28, 2024. Its market cap has decreased by -34.53% in one year.
Market Cap
440.98M
Enterprise Value
372.32M
1-Year Change
-34.53%
Ranking
Category
Stock Price
$7.53
Market Cap Chart
Since July 25, 2019, Health Catalyst's market cap has decreased from $1.37B to $440.98M, a decrease of -67.91%. That is a compound annual growth rate of -21.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 441.00M | 1.22% |
Mar 27, 2024 | 435.70M | -0.66% |
Mar 26, 2024 | 438.60M | 0.25% |
Mar 25, 2024 | 437.50M | -4.35% |
Mar 22, 2024 | 457.40M | -3.68% |
Mar 21, 2024 | 474.90M | 0.74% |
Mar 20, 2024 | 471.40M | 1.64% |
Mar 19, 2024 | 463.80M | 4.06% |
Mar 18, 2024 | 445.70M | -2.69% |
Mar 15, 2024 | 458.00M | 0.26% |
Mar 14, 2024 | 456.80M | -4.17% |
Mar 13, 2024 | 476.70M | -0.13% |
Mar 12, 2024 | 477.30M | -5.01% |
Mar 11, 2024 | 502.50M | -1.82% |
Mar 8, 2024 | 511.80M | -1.92% |
Mar 7, 2024 | 521.80M | 0.44% |
Mar 6, 2024 | 519.50M | 2.55% |
Mar 5, 2024 | 506.60M | 4.86% |
Mar 4, 2024 | 483.10M | 2.35% |
Mar 1, 2024 | 472.00M | -3.12% |
Feb 29, 2024 | 487.20M | 1.95% |
Feb 28, 2024 | 477.90M | -1.81% |
Feb 27, 2024 | 486.70M | 7.65% |
Feb 26, 2024 | 452.10M | -0.77% |
Feb 23, 2024 | 455.60M | -8.15% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
OraSure Technologies | 448.68M |
Community Health Systems | 448.50M |
Arbutus Biopharma | 446.94M |
Harrow Health | 444.86M |
biote | 439.74M |
AEON Biopharma | 437.74M |
iTeos Therapeutics | 435.44M |
ZimVie | 433.61M |